Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Friday, October 18, 2013

Factoring the "what ifs" into supply forecasting: Why building a durable supply chain around a protocol is critical

Fisher Clinical Services
Answering the "What IF" Questions
Download this free white paper now.

Effective supply planning requires decision making that strikes a balance between what's known and unknown, risk and budget, the needs of the trial and those of patients. The ultimate goal is ensuring that the right patients receive the right drugs at the right time. Otherwise, everyone sponsors, investigators, patients and society at large stands to lose. This white paper goes into great detail on the topic, including "what-if" scenarios, real-life disasters, and 15 industry references to additional information.

Provided by: Fisher Clinical Services

white paper

0 comments:

Post a Comment